Want to see HK:1951 full AI Analyst Report?
1951 Stock Chart & Stats
HK$2.21
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$2.21
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.92 - HK$3.51
Previous CloseN/A
Volume3.76M
Average Volume (3M)20.30M
Market Cap
HK$5.71B
Enterprise ValueHK$8.79K
Total Cash (Recent Filing)HK$906.17M
Total Debt (Recent Filing)HK$2.96B
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Aug 21, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield2.01%
Share Statistics
EPS (TTM)-0.36
Shares Outstanding2,705,044,000
10 Day Avg. Volume21,878,483
30 Day Avg. Volume20,304,545
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.64
Price to Sales (P/S)2.27
P/FCF Ratio26.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.10Price Target Upside40.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.09
Revenue Forecast (FY)HK$2.82B
Bulls Say, Bears Say
Bulls Say
Manageable LeverageModerate leverage and substantial equity provide financial flexibility for a healthcare services operator. This balance-sheet position can help Jinxin absorb earnings volatility and fund ongoing operations without relying excessively on additional borrowing.
Positive Operating Cash FlowConsistently positive operating cash flow indicates that the core fertility services business continues to generate cash despite recent earnings pressure. This supports operating resilience and provides an internal source of funding for recurring needs.
Underlying Operating ProfitabilityPositive operating and EBITDA margins show that the underlying service platform retains earnings capacity even after the reported net loss. Maintaining this operating profitability could support recovery if revenue stabilizes and exceptional pressures ease.
Bears Say
Revenue ContractionThe reversal from prior expansion to declining revenue signals weaker demand, utilization, pricing, or contribution from operating facilities. Sustained contraction would reduce scale benefits and make it harder to restore profitability across the fertility services network.
Large Net LossThe sharp move into a substantial net loss materially weakens returns and signals that operating profitability is not currently translating into shareholder earnings. A prolonged loss could constrain investment capacity and undermine confidence in the business model.
Free Cash Flow DeteriorationLower free cash flow reduces financial flexibility after operating requirements and capital spending. Combined with the net loss, the decline suggests weaker cash conversion and could limit the company’s ability to invest in facilities, technology, or expansion.
Jinxin Fertility Group Ltd. News
1951 FAQ
What was Jinxin Fertility Group Ltd.’s price range in the past 12 months?
Jinxin Fertility Group Ltd. lowest stock price was HK$1.92 and its highest was HK$3.51 in the past 12 months.
What is Jinxin Fertility Group Ltd.’s market cap?
Jinxin Fertility Group Ltd.’s market cap is HK$5.71B.
When is Jinxin Fertility Group Ltd.’s upcoming earnings report date?
Jinxin Fertility Group Ltd.’s upcoming earnings report date is Aug 21, 2026 which is in 2 days.
How were Jinxin Fertility Group Ltd.’s earnings last quarter?
Jinxin Fertility Group Ltd. released its earnings results on Mar 26, 2026. The company reported HK$0.035 earnings per share for the quarter, the consensus estimate of HK$0.035 by HK$0.
Is Jinxin Fertility Group Ltd. overvalued?
According to Wall Street analysts Jinxin Fertility Group Ltd.’s price is currently Undervalued.
Does Jinxin Fertility Group Ltd. pay dividends?
Jinxin Fertility Group Ltd. pays a Notavailable dividend of HK$0.042 which represents an annual dividend yield of 2.01%. See more information on Jinxin Fertility Group Ltd. dividends here
What is Jinxin Fertility Group Ltd.’s EPS estimate?
Jinxin Fertility Group Ltd.’s EPS estimate is 0.03.
How many shares outstanding does Jinxin Fertility Group Ltd. have?
Jinxin Fertility Group Ltd. has 2,705,044,000 shares outstanding.
What happened to Jinxin Fertility Group Ltd.’s price movement after its last earnings report?
Jinxin Fertility Group Ltd. reported an EPS of HK$0.035 in its last earnings report, expectations of HK$0.035. Following the earnings report the stock price went up 2.681%.
Which hedge fund is a major shareholder of Jinxin Fertility Group Ltd.?
Currently, no hedge funds are holding shares in HK:1951
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Jinxin Fertility Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.67%
12-Months-Change
Fundamentals
Return on Equity
2.01%
Trailing 12-Months
Asset Growth
-2.46%
Trailing 12-Months
Company Description
Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. (1951) is a China-based fertility services provider focused on assisted reproductive services. The group operates in the healthcare sector, providing services associated with fertility treatment, including assisted reproductive technology (ART) and related clinical services delivered through its network of fertility hospitals/clinics.
1951 Stock 12 Month Forecast
Average Price Target
HK$3.10
▲(40.27% Upside)
Technical Analysis
Aidigong Maternal & Child Health
―
Kindstar Globalgene Technology, Inc.
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Concord Healthcare Group Co., Ltd. Class H
―